"Vernalis became the latest takeover target in the biotechnology sector yesterday after it cut 60 per cent of its workforce, parted with its chief executive and put its American operations up for sale."
http://business.timesonline.co.uk/tol/business/industry_sectors/health/article3406179.ece
Thursday, February 21, 2008
VER
